From MSN News Update just now!
Schering-Plough unit probed
Criminal investigation centers on illegal sales, pricing
NEW YORK, May 30 — Schering-Plough Corp. said Friday one of its units is the target of a criminal investigation into practices that include the alleged sale of misbranded or unapproved drugs, submitting false drug pricing information to the government, and obstruction of justice.
THE KENILWORTH, New Jersey-based drug company said it received a letter from the U.S. Attorney’s Office for the District of Massachusetts saying its Schering Corp. subsidiary is the target of a federal grand jury investigation.
The company had previously revealed that the U.S. Attorney’s Office was investigating its sales, marketing and clinical trial practices.
The latest letter goes further, charging the company with destroying documents and obstructing justice related to the government’s investigation.
The company said it understands that based on the Department of Justice guidelines, receipt of such a letter indicates the government intends to pursue an indictment and believes it has substantial evidence to support an indictment.
